A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Public ClinicalTrials.gov record NCT00002187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
Study identification
- NCT ID
- NCT00002187
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina - Vitreous Associates Med Group | Los Angeles | California | 90017 | — |
| Community Eye Med Group | Pasadena | California | 911052536 | — |
| Univ of California San Francisco / SF Gen Hosp | San Francisco | California | 94110 | — |
| Dr Jacob Lalezari | San Francisco | California | 94115 | — |
| Dr Alan Palestine | Washington D.C. | District of Columbia | 20006 | — |
| Dr Julio Perez | Fort Lauderdale | Florida | 33060 | — |
| Georgia Retina | Atlanta | Georgia | 30327 | — |
| Chicago Ctr for Clinical Research | Chicago | Illinois | 60610 | — |
| Univ of Illinois | Chicago | Illinois | 60612 | — |
| Indiana Univ Med Ctr | Indianapolis | Indiana | 46202 | — |
| New York Univ Med Ctr | New York | New York | 10016 | — |
| Vitreo - Retinal Consultants | New York | New York | 10028 | — |
| Charlotte Eye Ear Nose & Throat Association | Charlotte | North Carolina | 28204 | — |
| Duke Univ | Durham | North Carolina | 27710 | — |
| Hahnemann Univ Hosp | Philadelphia | Pennsylvania | 191021192 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Novum Inc | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002187 live on ClinicalTrials.gov.